MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2337/dc25-1704

Медицинская библиотека · Diabetes care · 2026

Maternal and Neonatal Complications in Pregnant Women With Polyendocrine Metabolic Ovarian Syndrome: A Nested Prospective Cohort Study.

Neven Adriana C H, Sethi Parneet, Hague William M, Cheung N Wah, Hibbert Emily J, Nolan Christopher J, Peek Michael J, Wong Vincent, Flack Jeff R, Mclean Mark, Sweeting Arianne, Kautzky-Willer Alexandra, Harreiter Jürgen, Gianatti Emily, Mohan Viswanathan, Backman Helena, Bahri Khomami Mahnaz, Jona Eveline, Moran Lisa, Enticott Joanne, Mousa Aya, Boyle Jacqueline A, Simmons David, Teede Helena, TOBOGM Research Group*

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To investigate associations between polyendocrine metabolic ovarian syndrome (PMOS) and maternal and neonatal outcomes and explore interactions with BMI and ethnicity.

RESEARCH DESIGN AND

METHODS

This was a prospective nested cohort study of pregnant women with risk factors for hyperglycemia enrolled in an international, multicenter, randomized controlled trial of gestational diabetes mellitus (GDM) treatment. We compared baseline and pregnancy characteristics, evaluated adverse maternal and neonatal outcomes by PMOS status, and used multivariable regression models to evaluate factors (maternal age, baseline BMI, ethnicity, parity, smoking, and level of education) that independently affected maternal and neonatal outcomes.

RESULTS

Of 3,645 participants, PMOS prevalence was 17.1% (95% CI 15.9, 18.3). At booking visits, women with PCOS (vs. without) were younger (30.6 ± 4.7 vs. 31.3 ± 5.2 years; P < 0.001) and had higher median (interquartile range) BMI at baseline (29.8 [25.1-35.7] vs. 28.1 [24.1-33.9] kg/m2; P < 0.001), and more were primigravid (30.2% [n = 188] vs. 25.7% [n = 778]; P = 0.022). There were positive associations between PCOS and early GDM, with an adjusted odds ratio (aOR) of 1.37 (95% CI 1.10, 1.72), a composite of adverse neonatal outcomes (aOR 1.28 [95% CI 1.04, 1.58]), admission to a neonatal special care nursery or neonatal intensive care unit (aOR 1.32 [95% CI 1.05-1.65]), and negative associations between PMOS and gestational age at birth (-1.60 days [95% CI -2.82, -0.39]) and birth length (-0.33 cm [95% CI -0.61, -0.04]). No interactions were found with baseline BMI and ethnicity.

CONCLUSIONS

PMOS was associated with higher odds of early GDM, and neonatal outcomes were poorer on adjusted analyses, highlighting independent pregnancy risks in PMOS and the need to identify, monitor, and treat women with PMOS to mitigate risks of adverse pregnancy outcomes.

Для цитирования: Neven Adriana C H, Sethi Parneet, Hague William M, Cheung N Wah, Hibbert Emily J, Nolan Christopher J, Peek Michael J, Wong Vincent, Flack Jeff R, Mclean Mark, Sweeting Arianne, Kautzky-Willer Alexandra, Harreiter Jürgen, Gianatti Emily, Mohan Viswanathan, Backman Helena, Bahri Khomami Mahnaz, Jona Eveline, Moran Lisa, Enticott Joanne, Mousa Aya, Boyle Jacqueline A, Simmons David, Teede Helena, TOBOGM Research Group*. Maternal and Neonatal Complications in Pregnant Women With Polyendocrine Metabolic Ovarian Syndrome: A Nested Prospective Cohort Study.. Diabetes care. 2026. DOI: 10.2337/dc25-1704.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.